← All candidates
4 insider filings on record.
4 filings on record.
WGSGeneDx Holdings Corp.
NasdaqGS · Healthcare · $2.82B
$94.64
+5.46% · Sep 15
4 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 2 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what WGS ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$2.82B
Float
20.5M
69% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
81.0
Price / sales
6.2
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$90.44 avg target
-4.4% vs today · 9 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q2 '26$0.01 act+$0.20
Q1 '26−$0.28 act−$0.26
Q4 '25$0.14 act+$0.02
Q3 '25$0.49 act+$0.07
Coverage
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?Zacks · 3w agoGeneDx (WGS) Q2 2026 Earnings Call TranscriptMotley Fool · 08-11GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From BlackstoneSimply Wall St. · 08-08GeneDx Holdings Corp. Q2 2026 Earnings Call SummaryMoby · 08-04
The file stays open
4 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice